Ceftiofur (Ceftiofur ) - Uses, Dosage and Side Effects

Ceftiofur for dogs and cats is a third-generation cephalosporin antibiotic. It is broadly active against Gram-negative and Gram-positive bacteria and is used to manage serious bacterial infections that require parenteral (injectable) antibiotic therapy rather than oral treatment.

Dogs and cats recovering from bite wounds or orthopaedic surgeries complicated by infection are among those commonly managed with injectable cephalosporins like ceftiofur.

Ceftiofur kills susceptible bacteria by interfering with enzymes that build and maintain the bacterial cell wall. Without a stable cell wall, the bacteria eventually rupture and die.

Because ceftiofur belongs to the beta-lactam group of antibiotics, bacterial resistance can occur, particularly when antibiotics are used unnecessarily or for an inappropriate duration. For this reason, culture and susceptibility testing can be particularly useful in complicated or recurrent infections.

Ceftiofur works in cats through the same basic mechanism: it disrupts bacterial cell-wall synthesis and kills susceptible bacteria.

Its use in cats should be based on the suspected or confirmed bacterial infection, because not all organisms are susceptible to ceftiofur and some infections are better treated with other antibiotics.

Ceftiofur dosage for dogs is weight-based and administered by subcutaneous or intramuscular injection by a veterinary professional or under explicit veterinary instruction for home administration. The formulation used determines the injection frequency. Standard formulations are given daily, while extended-release crystalline formulations are given every 3 to 7 days depending on the clinical protocol. Do not adjust the dose or injection interval without veterinary guidance, as underdosing promotes antibiotic resistance.

Ceftiofur use in puppies requires careful, weight-based dosing and a veterinary assessment of infection severity and the causative organism. Puppies with serious bacterial infections, particularly those secondary to parvoviral disease or bite wounds, may require injectable antibiotic therapy, and ceftiofur may be a practical option.

The dosing approach is the same across all size groups. Small dogs receive a lower total dose based on body weight. Weigh the dog accurately before each injection to ensure correct dosing. Rotate the injection site between doses in small dogs to reduce localised tissue irritation.

Weight-based dosing and veterinary-specified injection frequency apply consistently. Culture and sensitivity testing before prescribing ceftiofur for medium dogs with recurrent infections ensures appropriate antibiotic selection.

Large dogs require higher total doses based on body weight. Extended-release formulations are particularly practical in large breeds where daily injectable antibiotic administration is challenging. Follow your vet's injection interval instructions precisely to maintain consistent antibiotic blood levels throughout treatment.

Ceftiofur dosage for cats is weight-based and administered by subcutaneous injection. Injection frequency depends on the prescribed formulation. Cats with severe respiratory infections, septicaemia, or urinary tract infections requiring parenteral therapy may receive ceftiofur as the primary antibiotic or as part of a combination protocol. Your pet health expert will determine the appropriate formulation and injection schedule based on the infection severity and clinical response.

Kittens with serious bacterial infections need veterinary assessment before starting injectable antibiotic therapy. Ceftiofur dosage in kittens requires precise weight-based calculation, and the injection site must be carefully selected to minimise discomfort in young, small patients. Monitor closely for signs of injection-site reactions after each dose.

Ceftiofur is generally well tolerated. Side effects are uncommon at recommended doses.

Cats may experience injection-site swelling, mild lethargy, and reduced appetite. Gastrointestinal upset is less common in cats than in dogs with parenteral cephalosporin use. Cats with known penicillin or cephalosporin hypersensitivity should not receive ceftiofur. Any facial swelling, respiratory changes, or collapse after injection requires immediate veterinary assessment at the nearest 24/7 cat emergency care.

Ceftiofur overdose in dogs may cause vomiting, diarrhoea, significant injection-site reactions, and in severe cases, neurological signs at very high doses. Because ceftiofur is administered by injection rather than orally, dosing errors are less common than with oral antibiotics but require careful weight-based calculation to avoid. Seek immediate veterinary care if overdose is suspected.

Cats are more sensitive to medication errors because of their smaller body size and reduced hepatic metabolic capacity. Possible signs of ceftiofur overdose include vomiting, severe lethargy, injection-site necrosis, and rare neurological signs. Contact your vet immediately if accidental overdose occurs or if a cat shows unexpected clinical deterioration after a ceftiofur injection.

Store ceftiofur injectable formulations according to the specific product instructions, as storage requirements vary between standard and extended-release formulations. Most require refrigeration between 2°C and 8°C and protection from light. Shake extended-release suspensions thoroughly before drawing each dose. Do not freeze. Discard opened vials within the period specified by the manufacturer. Store out of reach of children and pets.

Contact your vet if your pet develops significant injection-site swelling, pain, or discharge; persistent vomiting; complete appetite loss; or no improvement in the infection within 3 to 5 days of starting ceftiofur treatment. Also seek advice if your pet develops facial swelling, breathing difficulty, or collapse after injection, as these may indicate a hypersensitivity reaction requiring emergency management. Worsening infection despite antibiotic therapy warrants culture and sensitivity retesting.

Ceftiofur for dogs and cats is a third-generation injectable cephalosporin antibiotic used to manage serious Gram-negative and Gram-positive bacterial infections. Its extended-release formulations improve practicality in clinical and home-injection settings, reducing the injection frequency required for effective treatment. Accurate weight-based dosing, correct injection technique, and completing the full prescribed course are essential for clinical success and responsible antibiotic stewardship in veterinary practice.